Song Gao

Trials

Studies that name Song Gao as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:07 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07436741 · Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

  Tianjin Medical University Cancer Institute and Hospital · recruiting · Pancreatic Cancer, Adult · principal investigator
• Ph3
  NCT06333821 · A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

  Biotech Pharmaceutical Co., Ltd. · not yet recruiting · Cervical Cancer · study chair
• Ph2
  NCT05908747 · Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer

  Tianjin Medical University Cancer Institute and Hospital · completed · Pancreatic Cancer · principal investigator
• Ph1/Ph2
  NCT03615313 · PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor

  Shanghai Cell Therapy Research Institute · unknown · Advanced Solid Tumor · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:07 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 15 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.